1/We should consider the additive benefits of #GDMT during MCS for #Cardshock. Recently, we looked at the effect of implementing a protocol for aggressive GDMT uptitration during @jjmt_heartrecov Impella support. There is a free link (only 50 first) to the publication in the end
Many thanks to @Babar_Basir who is the Editor of an MCS issue of interventional cardiology clinics to invite our team to write on hemolysis, which is a very timely topic after Danger Shock.
Free link to the paper: https://t.co/XWCFBNiLbK
@thiele_holger@JACCJournals Great work. Do you think lactate clearance was different? To me still seem different diseases looking alike: CA leading to SIRS where lactate is in part from arrest Vs pure CS where a low CO state drives towards hypoperfusion;lactate is reflecting ongoing cardiac dysfunction
Key take-home messages from @TimBalthazar wonderfull lecture about optimising management strategies after mechanical circulatory support during #ACVC26
I hope I will finally stop seeing so much aspirin on top of OAC. Before this study it already seemed a bad idea but now more evidence
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine https://t.co/sXhkUhNXL8
What a pleasure to discuss inotropes and vasoactive drugs with the bright @LucaFazziniMD in the @escardio HFA cardiotalk. However, more questions than answers on this topic.
Open access:
https://t.co/UEZR4orqfS
END OF DAY 1️⃣ at the ACVC/EAPCI #CardiogenicShockSchool in Paris
👫 More than 9️⃣0️⃣ participants
🎯 4️⃣Sessions packed with outstanding lectures
💪 4️⃣Hands-on workshops:
🔴 Access&Closure
🟢 Impella Placement
🔵 Haemodynamic Management
🟡 ECMO Management
True #TeamWork with #ACVC for the community 🫶
#EAPCI and #ACVC_ESC join forces for a unique event on #CardShock
https://t.co/IcW5jK6Bao
90 Participants 💪
7 sessions🔥
4 workshops 💼
Thank you all for making this event a BIG success
Mant thanks to Prof Luscher for his welcome and talk🙏
Stay tuned for level 2 in January in Barcelona
https://t.co/ycbAUqVChu
NEW ACVC-EAPCI Cardiogenic Shock School - Level 1
8-9 September in Paris (France)
If you are new to #MCS or about to introduce this technology in your centre in France, you can apply for a grant here! https://t.co/8DDqWvsOt2
For full info on the programme click here:
https://t.co/IcW5jK6Bao
#ACVC_ESC #EAPCI #cvacute #CardShock @EAPCIPresident@escardio
Muy interesante y disrruptivo el estudio hecho por el grupo de @FH_Verbrugge
1. Es factible el inicio de la cuádruple terapia en pacientes con Choque Cardiogenico SCAI D/E?
#cardiogenicshock#heartfailure#impella
https://t.co/XihwU1XCyl
@drandrewsharp I don't say you should give ARNI on pressors but there is no reason why sglt2 and spiro would pose a big issue. We see no increase in pressor dose with these.
1/We should consider the additive benefits of #GDMT during MCS for #Cardshock. Recently, we looked at the effect of implementing a protocol for aggressive GDMT uptitration during @jjmt_heartrecov Impella support. There is a free link (only 50 first) to the publication in the end